TheraRadar
← Back
Data updated: Mar 29, 2026

KRKA TOVARNA ZDRAVIL

Infectious DiseaseGastroenterologyNeurology
Generics

KRKA TOVARNA ZDRAVIL is a generic drug manufacturer focused on Infectious Disease, Gastroenterology, Neurology.

2013
Since
1
Drugs
-
Trials
23
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

LANSOPRAZOLE 2025-09-16
Labeling
LANSOPRAZOLE 2025-09-16
Labeling
LANSOPRAZOLE 2025-09-16
Labeling
LANSOPRAZOLE 2025-09-16
Labeling
LANSOPRAZOLE 2025-08-15
Labeling
LANSOPRAZOLE 2025-03-12
Labeling
LANSOPRAZOLE 2024-12-19
Labeling
LANSOPRAZOLE 2024-12-19
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 43%
1 drugs
Gastroenterology 43%
1 drugs
Neurology 7%
0 drugs Phase 1: 1
Cardiovascular 7%
0 drugs Phase 1: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

WARNER CHILCOTT LLC specialty
Cardiovascular, Neurology, Gastroenterology, Infectious Disease
Bristol-Myers Squibb big-pharma
Gastroenterology, Infectious Disease, Neurology
GE HEALTHCARE specialty
Infectious Disease, Neurology, Cardiovascular
APOTHECON specialty
Infectious Disease, Cardiovascular, Gastroenterology
Novo Nordisk big-pharma
Cardiovascular, Infectious Disease, Neurology